Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit

Fluxion Biosciences, Inc. announced the release of a new reagent kit for the IsoFlux System designed to provide more options for circulating tumor cell (CTC) and other rare cell capture from biological samples. The IsoFlux Rare Cell Enrichment (Streptavidin) Kit incorporates streptavidin-coated magnetic beads that can bind with one or more biotinylated antibodies targeted towards cell-surface markers on the cells of interest. This new kit facilitates capture of targeted rare cell populations that can include: CTCs, cells undergoing epithelial to mesenchymal transition (EMT), cells expressing a particular drug or disease target, stem cells, and immune cells.

Similar to the existing IsoFlux enrichment kits, the IsoFlux Rare Cell Enrichment (Streptavidin) Kit utilizes an advanced microfluidic technology to achieve targeted, high sensitivity rare cell capture. The cells collected with this kit are immediately ready for downstream analysis, including qPCR (gene expression, genotyping), next-generation sequencing (NGS), and immunofluorescence imaging. The samples are optimized for molecular analysis and feature high cell recovery, minimal background cells, and low-volume elution.

"The IsoFlux System has been adopted by labs across the world that continue to identify new applications," said Michael Schwartz, Program Director. "Many of these new applications benefit from the well understood and utilized streptavidin-biotin chemistry. This new kit provides a simple, off-the-shelf reagent kit that can target a wide variety of cell types using familiar chemistry."

The IsoFlux Rare Cell Enrichment (Streptavidin) Kit is available immediately.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Fluxion Biosciences. (2019, June 19). Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit. News-Medical. Retrieved on June 18, 2024 from https://www.news-medical.net/news/20140121/Fluxion-Biosciences-announces-release-of-IsoFlux-Rare-Cell-Enrichment-Kit.aspx.

  • MLA

    Fluxion Biosciences. "Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit". News-Medical. 18 June 2024. <https://www.news-medical.net/news/20140121/Fluxion-Biosciences-announces-release-of-IsoFlux-Rare-Cell-Enrichment-Kit.aspx>.

  • Chicago

    Fluxion Biosciences. "Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit". News-Medical. https://www.news-medical.net/news/20140121/Fluxion-Biosciences-announces-release-of-IsoFlux-Rare-Cell-Enrichment-Kit.aspx. (accessed June 18, 2024).

  • Harvard

    Fluxion Biosciences. 2019. Fluxion Biosciences announces release of IsoFlux Rare Cell Enrichment Kit. News-Medical, viewed 18 June 2024, https://www.news-medical.net/news/20140121/Fluxion-Biosciences-announces-release-of-IsoFlux-Rare-Cell-Enrichment-Kit.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluxion Biosciences to defend against alleged automated patch clamp system patent infringement lawsuit